Eric Lefkofsky, co-founder of Tempus Labs, started the company about three years ago. The company works with the National Cancer Institutes full service cancer centers in the US. They provide innovative services; cancer testing, sequencing of cancer patients and DNA, liquid biopsy of DNA, RNA sequencing, and tumor classification according to a patient’s immune system.
After testing the patients they analyze the data to help find the best treatment for each patient by analyzing data from similar cases. Tempus Labs developed the technologies of gene therapy and editing. It is used to develop treatments to helps fight chronic diseases with no solutions.
They developed a drug to treat a rare form of vision loss. The drug is injected into the eye and approved by the FDA. It was developed by Sparks Therapeutics in 2017.
Tempus Labs worked with Stanford University on devising a way to diagnose skin cancer. Physicians now have the ability to diagnose both benign and malignant growths. Another company Tempus Labs worked with AliveCor developed a device that tracks a person’s heart rate and warn them when it is too high.
Their associates created glucose sensors that are used to directly dose insulin to patients. One is applied directly to the arm, and does not require calibration. The other device monitors blood glucose in patients by attaching to the arm or abdomen. The results are sent to a watch or smartphone.
Tempus Labs has developed many medications, and devices with their associates to help treat cancer too. Two drugs from Kite Phrama fight aggressive Hodgkin lymphoma and provide treatment for children, and young adults with lymphoblastic leukemia. Another company Ormon received FDA approval for a watch that reads blood pressure.
Eric Lefkofsky is a philanthropist too. He is a trustee with the Lurie Children Hospital in Chicago, The Art Institute, and Museum of Science and Industry. He and his wife founded the Lefkofsky Family Foundation an organization that promotes human rights, advancement in education, and arts and culture in the community.
He received his Juris Doctor from the University of Michigan Law School, and is an adjunct professor at the University of Chicago.
To Know More Click Here